Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycine max L. Merrill) in rats with estradiol valerate-induced polycystic ovary syndrome as an inflammatory state

References

• Sørensen AE, Wissing ML, Salö S, et al. MicroRNAs related to polycystic ovary syndrome (PCOS). Genes. 2014;5:684–708.
   PubMed Web of Science ®Google Scholar
• Ojeda-Ojeda M, Murri M, Insenser M, et al. Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS). Curr Pharm Des. 2013;19:5775–5791.
   PubMed Web of Science ®Google Scholar
• Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016;2016:1.
   Web of Science ®Google Scholar
• Huang CC, Hsu BY, Wu NL, et al. Anti-photoaging effects of soy isoflavone extract (aglycone and acetylglucoside form) from soybean cake. Int J Mol Sci. 2010;11:4782–4795.
   PubMed Web of Science ®Google Scholar
• Alghamdi SS, Khan MA, El-Harty EH, et al. Comparative phytochemical profiling of different soybean (Glycine max (L.) Merr) genotypes using GC-MS. Saudi J Biol Sci. 2018;25:15–21.
   PubMed Web of Science ®Google Scholar
• Dixit AK, Bhatnagar D, Kumar V, et al. Gamma irradiation induced enhancement in isoflavones, total phenol, anthocyanin and antioxidant properties of varying seed coat colored soybean. J Agric Food Chem. 2010;58:4298–4302.
   PubMed Web of Science ®Google Scholar
• Yu J, Bi X, Yu B, et al. Isoflavones: anti-inflammatory benefit and possible caveats. Nutrients. 2016;8:pii: E361.
   Web of Science ®Google Scholar
• Kalaiselvan V, Kalaivani M, Vijayakumar A, et al. Current knowledge and future direction of research on soy isoflavones as a therapeutic agents. Phcog Rev. 2010;4:111–117.
   Google Scholar
• Lakshmi MC, Rao LJ, Ravi R, et al. Extraction and concentration of isoflavones from soybean (Glycine max). Separat Sci Technol. 2013;48:166–174.
   Web of Science ®Google Scholar
• Yatsu FKJ, Koester LS, Bassani VL. Isoflavone-aglycone fraction from Glycine max: a promising raw material for isoflavone-based pharmaceutical or nutraceutical products. Revista Brasileira de Farmacognosia. 2016;26:259–267.
   Google Scholar
• Kumar V, Rani A, Dixit AK, et al. A comparative assessment of total phenolic content, ferric reducing-anti-oxidative power, free radical-scavenging activity, vitamin C and isoflavones content in soybean with varying seed coat colour. Food Res Int. 2010;43:323–328.
   Web of Science ®Google Scholar
• Mesbah F, Moslem M, Vojdani Z, et al. Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats. J Ovarian Res. 2015;8:74.
   PubMed Web of Science ®Google Scholar
• Baravalle C, Salvetti NR, Mira GA, et al. The role of ACTH in the pathogenesis of polycystic ovarian syndrome in rats: hormonal profiles and ovarian morphology. Physiol Res. 2007;56:67–78.
   PubMed Web of Science ®Google Scholar
• Mahamed RR, Maganhin CC, Sasso GRS, et al. Metformin improves ovarian follicle dynamics by reducing theca cell proliferation and CYP-17 expression in an androgenized rat model. J Ovarian Res. 2018;11:18.
   PubMed Web of Science ®Google Scholar
• Pedersen T, Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil. 1968;17:555–557.
   PubMedGoogle Scholar
• Gao L, Gu Y, Yin X. High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis. PloS One. 2016;11:e0164021.
   PubMed Web of Science ®Google Scholar
• Fulghesu AM, Sanna F, Uda S, et al. IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. Mediators Inflamm. 2011;2011:1.
   Google Scholar
• Hong L, Zhang Y, Wang Q, et al. Effects of interleukin 6 and tumor necrosis factor-α on the proliferation of porcine theca interna cells: possible role of these cytokines in the pathogenesis of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2016;55:183–187.
   PubMed Web of Science ®Google Scholar
• Ebejer K, Calleja-Agius J. The role of cytokines in polycystic ovarian syndrome. Gynecol Endocrinol. 2013;29:536–540.
   PubMed Web of Science ®Google Scholar
• Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17:17–33.
   PubMed Web of Science ®Google Scholar
• Spaczynski RZ, Arici A, Duleba AJ. Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells. Biol Reprod. 1999;61:993–998.
   PubMed Web of Science ®Google Scholar
• Gonzalez F, Rote NS, Minium J, et al. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome. J Endocrinol. 2006;188:521–529.
   PubMed Web of Science ®Google Scholar
• Duleba AJ, Foyouzi N, Karaca M, et al. Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress. Hum Reprod (Oxford, England). 2004;19:1519–1524.
   PubMed Web of Science ®Google Scholar
• Wang S, He G, Chen M, et al. The role of antioxidant enzymes in the ovaries. Oxidat Med Cell Longev. 2017;2017:1.
   Google Scholar
• Desjardins GC, Beaudet A, Brawer JR. Alterations in opioid parameters in the hypothalamus of rats with estradiol-induced polycystic ovarian disease. Endocrinology. 1990;127:2969–2976.
   PubMed Web of Science ®Google Scholar
• Fanti P, Asmis R, Stephenson TJ, et al. Positive effect of dietary soy in ESRD patients with systemic inflammation–correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant. 2006;21:2239–2246.
   PubMed Web of Science ®Google Scholar
• Danciu C, Antal DS, Ardelean F, et al. New insights regarding the potential health benefits of isoflavones. In: Justino GC, editor. Flavonoids - from biosynthesis to human health. Rijeka, Croatia: Intech; 2017. p. 257–286.
   Google Scholar
• Saha S, Sadhukhan P, Sil PC. Genistein: a phytoestrogen with multifaceted therapeutic properties. Mini Rev Med Chem. 2014;920–940.
   PubMed Web of Science ®Google Scholar
• Carrara V. D S, Amado CB, de Melo JO, et al. Evaluation of soybean methanol fraction on acute inflammation. J Med Food. 2011;14:1570–1575.
   PubMed Web of Science ®Google Scholar
• Rajan RK, M SS, Balaji B. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism. Pharm Biol. 2017;55:242–251.
   PubMed Web of Science ®Google Scholar